English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/217846
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Accumulation of perfluoroalkyl substances in human tissues

AuthorsPérez, Francisca; Nadal, M.; Navarro-Ortega, Alícia ; Fàbrega, F.; Domingo, J.L.; Barceló, Damià ; Farré, Marinella
Issue Date2013
PublisherPergamon Press
CitationEnvironmental International 59: 354- 362 (2013)
AbstractPerfluoroalkyl substances (PFASs) are environmental pollutants with an important bioaccumulation potential. However, their metabolism and distribution in humans are not well studied. In this study, the concentrations of 21 PFASs were analyzed in 99 samples of autopsy tissues (brain, liver, lung, bone, and kidney) from subjects who had been living in Tarragona (Catalonia, Spain). The samples were analyzed by solvent extraction and online purification by turbulent flow and liquid chromatography coupled to tandem mass spectrometry. The occurrence of PFASs was confirmed in all human tissues. Although PFASs accumulation followed particular trends depending on the specific tissue, some similarities were found. In kidney and lung, perfluorobutanoic acid was the most frequent compound, and at highest concentrations (median values: 263 and 807. ng/g in kidney and lung, respectively). In liver and brain, perfluorohexanoic acid showed the maximum levels (median: 68.3 and 141. ng/g, respectively), while perfluorooctanoic acid was the most contributively in bone (median: 20.9. ng/g). Lung tissues accumulated the highest concentration of PFASs. However, perfluorooctane sulfonic acid and perfluorooctanoic acid were more prevalent in liver and bone, respectively. To the best of our knowledge, the accumulation of different PFASs in samples of various human tissues from the same subjects is here reported for the very first time. The current results may be of high importance for the validation of physiologically based pharmacokinetic models, which are being developed for humans. However, further studies on the distribution of the same compounds in the human body are still required. © 2013 Elsevier Ltd.
Publisher version (URL)http://dx.doi.org/10.1016/j.envint.2013.06.004
URIhttp://hdl.handle.net/10261/217846
Identifiersdoi: 10.1016/j.envint.2013.06.004
issn: 0160-4120
Appears in Collections:(IDAEA) Artículos
Files in This Item:
File Description SizeFormat 
1-s2.0-S0160412013001220-main.pdf709,52 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.